Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
10
NMPA:10
Drug Approvals
Cisatracurium Besilate Injection
- Product Name
- 苯磺顺阿曲库铵注射液
- Approval Number
- 国药准字H20254237
- Approval Date
- May 20, 2025
NMPA
Cisatracurium Besilate Injection
- Product Name
- 苯磺顺阿曲库铵注射液
- Approval Number
- 国药准字H20254236
- Approval Date
- May 20, 2025
NMPA
Compound Troxerutin and Poreine Cerebroside Injection
- Product Name
- 复方曲肽注射液
- Approval Number
- 国药准字H22026578
- Approval Date
- Aug 10, 2020
NMPA
Compound Troxerutin and Poreine Cerebroside Injection
- Product Name
- 复方曲肽注射液
- Approval Number
- 国药准字H22026577
- Approval Date
- Aug 10, 2020
NMPA
Compound Troxerutin and Poreine Cerebroside Injection
- Product Name
- 复方曲肽注射液
- Approval Number
- 国药准字H22026579
- Approval Date
- Aug 10, 2020
NMPA
Compound Porcine Cerebroside and Ganglioside Injection
- Product Name
- 复方脑肽节苷脂注射液
- Approval Number
- 国药准字H22026457
- Approval Date
- Aug 10, 2020
NMPA
Compound Porcine Cerebroside and Ganglioside Injection
- Product Name
- 复方脑肽节苷脂注射液
- Approval Number
- 国药准字H22026472
- Approval Date
- Aug 10, 2020
NMPA
Compound Porcine Cerebroside and Ganglioside Injection
- Product Name
- 复方脑肽节苷脂注射液
- Approval Number
- 国药准字H22026502
- Approval Date
- Aug 10, 2020
NMPA
Ligustrazine Phosphate Injection
- Product Name
- 磷酸川芎嗪注射液
- Approval Number
- 国药准字H22026488
- Approval Date
- Aug 10, 2020
NMPA
Clinical Trials
No trials found
News
No news found